SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Abe M, Umehara F, Kubota R, Moritoyo T, Izumo S, Osame M. 1999. Activation of macrophages/microglia with the calcium-binding proteins MRP14 and MRP8 is related to the lesional activities in the spinal cord of HTLV-I associated myelopathy. J Neurol 246: 358364.
  • Adya N, Zhao LJ, Huang W, Boros I, Giam CZ. 1994. Expansion of CREB's DNA recognition specificity by Tax results from interaction with Ala-Ala-Arg at positions 282–284 near the conserved DNA-binding domain of CREB. Proc Natl Acad Sci USA 91: 56425646.
  • Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC. 1997. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 185: 111120.
  • Akbari O, DeKruyff RH, Umetsu DT. 2001. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2: 725731.
  • Albrecht B, Collins ND, Newbound GC, Ratner L, Lairmore MD. 1998. Quantification of human T-cell lymphotropic virus type 1 proviral load by quantitative competitive polymerase chain reaction. J Virol Methods 75: 123140.
  • Albrecht B, Collins ND, Burniston MT, Nisbet JW, Ratner L, Green PL, Lairmore MD. 2000. Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes. J Virol 74: 98289835.
  • Aloisi F, Ria F, Adorini L. 2000. Regulation of T-cell responses by CNS antigen-presenting cells: Different roles for microglia and astrocytes. Immunol Today 21: 141147.
  • Baggiolini M. 1998. Chemokines and leukocyte traffic. Nature 392: 565568.
  • Ballard DW, Bohnlein E, Lowenthal JW, Wano Y, Franza BR, Greene WC. 1988. HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene. Science 241: 16521655.
  • Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392: 245252.
  • Bangham CR. 2000. The immune response to HTLV-I. Curr Opin Immunol 12: 397402.
  • Baranger AM, Palmer CR, Hamm MK, Giebler HA, Brauweiler A, Nyborg JK, Schepartz A. 1995. Mechanism of DNA-binding enhancement by the human T-cell leukaemia virus transactivator Tax. Nature 376: 606608.
  • Barnhart MK, Connor LM, Marriott SJ. 1997. Function of the human T-cell leukemia virus type 1 21-base pair repeats in basal transcription. J Virol 71: 337344.
  • Bartoe JT, Albrecht B, Collins ND, Robek MD, Ratner L, Green PL, Lairmore MD. 2000. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. J Virol 74: 10941100.
  • Bazarbachi A, Huang M, Gessain A, Saal F, Saib A, Peries J, De The H, Galibert F. 1995. Human T-cell-leukemia virus type I in post-transfusional spastic paraparesis: Complete proviral sequence from uncultured blood cells. Int J Cancer 63: 494499.
  • Berlin-Rufenach C, Otto F, Mathies M, Westermann J, Owen MJ, Hamann A, Hogg N. 1999. Lymphocyte migration in lymphocyte function-associated antigen (LFA)-1-deficient mice. J Exp Med 189: 14671478.
  • Bertini R, Luini W, Sozzani S, Bottazzi B, Ruggiero P, Boraschi D, Saggioro D, Chieco-Bianchi L, Proost P, van Damme J, Mantovani A. 1995. Identification of MIP-1 alpha/LD78 as a monocyte chemoattractant released by the HTLV-I-transformed cell line MT4. AIDS Res Hum Retroviruses 11: 155160.
  • Bhagavati S, Ehrlich G, Kula RW, Kwok S, Sninsky J, Udani V, Poiesz BJ. 1988. Detection of human T-cell lymphoma/leukemia virus type I DNA and antigen in spinal fluid and blood of patients with chronic progressive myelopathy. N Engl J Med 318: 11411147.
  • Bhat NK, Thompson CB, Lindsten T, June CH, Fujiwara S, Koizumi S, Fisher RJ, Papas TS. 1990. Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: Regulatory role for the protooncogene ETS1. Proc Natl Acad Sci USA 87: 37233727.
  • Billon N, Carlisi D, Datto MB, van Grunsven LA, Watt A, Wang XF, Rudkin BB. 1999. Cooperation of Sp1 and p300 in the induction of the CDK inhibitor p21WAF1/CIP1 during NGF-mediated neuronal differentiation. Oncogene 18: 28722882.
  • Black AR, Black JD, Azizkhan-Clifford J. 2001. Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188: 143160.
  • Bosselut R, Duvall JF, Gegonne A, Bailly M, Hemar A, Brady J, Ghysdael J. 1990. The product of the c-ets-1 proto-oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T cell leukemia virus HTLV-1. Embo J 9: 31373144.
  • Bosselut R, Lim F, Romond PC, Frampton J, Brady J, Ghysdael J. 1992. Myb protein binds to multiple sites in the human T cell lymphotropic virus type 1 long terminal repeat and transactivates LTR-mediated expression. Virology 186: 764769.
  • Brady J, Jeang KT, Duvall J, Khoury G. 1987. Identification of p40x-responsive regulatory sequences within the human T-cell leukemia virus type I long terminal repeat. J Virol 61: 21752181.
  • Brauweiler A, Garl P, Franklin AA, Giebler HA, Nyborg JK. 1995. A molecular mechanism for human T-cell leukemia virus latency and Tax transactivation. J Biol Chem 270: 1281412822.
  • Buckle GJ, Hafler DA, Hollsberg P. 1996. HTLV-I-induced T-cell activation. J Acquir Immune Defic Syndr Hum Retrovirol 13: S107113.
  • Burton M, Upadhyaya CD, Maier B, Hope TJ, Semmes OJ. 2000. Human T-cell leukemia virus type 1 Tax shuttles between functionally discrete subcellular targets. J Virol 74: 23512364.
  • Chen IS, McLaughlin J, Golde DW. 1984. Long terminal repeats of human T-cell leukaemia virus II genome determine target cell specificity. Nature 309: 276279.
  • Cho I, Sugimoto M, Mita S, Tokunaga M, Imamura F, Ando M. 1995. In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis. Am J Trop Med Hyg 53: 412418.
  • Chou KS, Okayama A, Su IJ, Lee TH, Essex M. 1996. Preferred nucleotide sequence at the integration target site of human T-cell leukemia virus type I from patients with adult T-cell leukemia. Int J Cancer 65: 2024.
  • Ciminale V, Zotti L, D'Agostino DM, Ferro T, Casareto L, Franchini G, Bernardi P, Chieco-Bianchi L. 1999. Mitochondrial targeting of the p13II protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-I). Oncogene 18: 45054514.
  • Clark NM, Smith MJ, Hilfinger JM, Markovitz DM. 1993. Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor. J Virol 67: 55225528.
  • Colgin MA, Nyborg JK. 1998. The human T-cell leukemia virus type 1 oncoprotein Tax inhibits the transcriptional activity of c-Myb through competition for the CREB binding protein. J Virol 72: 93969399.
  • Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies O. 1995. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269: 15831585.
  • Corboy JR, Buzy JM, Zink MC, Clements JE. 1992. Expression directed from HIV long terminal repeats in the central nervous system of transgenic mice. Science 258: 18041808.
  • Daenke S, Nightingale S, Cruickshank JK, Bangham CR. 1990. Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates. J Virol 64: 12781282.
  • Datta S, Kothari NH, Fan H. 2000. In vivo genomic footprinting of the human T-cell leukemia virus type 1 (HTLV-1) long terminal repeat enhancer sequences in HTLV-1-infected human T-cell lines with different levels of Tax I activity. J Virol 74: 82778285.
  • DeKoter RP, Walsh JC, Singh H. 1998. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors. EMBO J 17: 44564468.
  • Derse D, Mikovits J, Ruscetti F. 1997. X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro. Virology 237: 123128.
  • Dhawan S, Weeks BS, Abbasi F, Gralnick HR, Notkins AL, Klotman ME, Yamada KM, Klotman PE. 1993. Increased expression of alpha 4 beta 1 and alpha 5 beta 1 integrins on HTLV-I-infected lymphocytes. Virology 197: 778781.
  • Dhib-Jalbut S, Hoffman PM, Yamabe T, Sun D, Xia J, Eisenberg H, Bergey G, Ruscetti FW. 1994. Extracellular human T-cell lymphotropic virus type I Tax protein induces cytokine production in adult human microglial cells. Ann Neurol 36: 787790.
  • Ding YH, Baker BM, Garboczi DN, Biddison WE, Wiley DC. 1999. Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. Immunity 11: 4556.
  • Ding W, Albrecht B, Luo R, Zhang W, Stanley JR, Newbound GC, Lairmore MD. 2001. Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12(I): Association with calreticulin and calnexin. J Virol 75: 76727682.
  • Fantuzzi L, Borghi P, Ciolli V, Pavlakis G, Belardelli F, Gessani S. 1999. Loss of CCR2 expression and functional response to monocyte chemotactic protein (MCP-1) during the differentiation of human monocytes: Role of secreted MCP-1 in the regulation of the chemotactic response. Blood 94: 875883.
  • Feuer G, Fraser JK, Zack JA, Lee F, Feuer R, Chen IS. 1996. Human T-cell leukemia virus infection of human hematopoietic progenitor cells: Maintenance of virus infection during differentiation in vitro and in vivo. J Virol 70: 40384044.
  • Fisher RC, Scott EW. 1998. Role of PU.1 in hematopoiesis. Stem Cells 16: 2537.
  • Fox RJ, Levin MC, Jacobson S. 1996. Tumor necrosis factor alpha expression in the spinal cord of human T-cell lymphotrophic virus type I associated myelopathy/tropical spastic paraparesis patients. J Neurovirol 2: 323329.
  • Franchini G, Mulloy JC, Koralnik IJ, Lo Monico A, Sparkowski JJ, Andresson T, Goldstein DJ, Schlegel R. 1993. The human T-cell leukemia/lymphotropic virus type I p12I protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase. J Virol 67: 77017704.
  • Franklin AA, Kubik MF, Uittenbogaard MN, Brauweiler A, Utaisincharoen P, Matthews MA, Dynan WS, Hoeffler JP, Nyborg JK. 1993. Transactivation by the human T-cell leukemia virus Tax protein is mediated through enhanced binding of activating transcription factor-2 (ATF-2) ATF-2 response and cAMP element-binding protein (CREB). J Biol Chem 268: 2122521231.
  • Fujii M, Sassone-Corsi P, Verma IM. 1988. c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 85: 85268530.
  • Fujii M, Niki T, Mori T, Matsuda T, Matsui M, Nomura N, Seiki M. 1991. HTLV-1 Tax induces expression of various immediate early serum responsive genes. Oncogene 6: 10231029.
  • Fujii M, Tsuchiya H, Chuhjo T, Akizawa T, Seiki M. 1992. Interaction of HTLV-1 Tax1 with p67SRF causes the aberrant induction of cellular immediate early genes through CArG boxes. Genes Dev 6: 20662076.
  • Fujii M, Tsuchiya H, Meng XB, Seiki M. 1995. c-Jun, c-Fos and their family members activate the transcription mediated by three 21-bp repetitive sequences in the HTLV-I long terminal repeat. Intervirology 38: 221228.
  • Furuya T, Nakamura T, Shirabe S, Nishiura Y, Tsujino A, Goto H, Nakane S, Eguchi K, Nakamura H, Nagataki S. 1997. Heightened transmigrating activity of CD4-positive T cells through reconstituted basement membrane in patients with human T-lymphotropic virus type I-associated myelopathy. Proc Assoc Am Physicians 109: 228236.
  • Furuya T, Nakamura T, Fujimoto T, Nakane S, Kambara C, Shirabe S, Hamasaki S, Motomura M, Eguchi K. 1999. Elevated levels of interleukin-12 and interferon-gamma in patients with human T lymphotropic virus type I-associated myelopathy. J Neuroimmunol 95: 185189.
  • Garboczi DN, Utz U, Ghosh P, Seth A, Kim J, VanTienhoven EA, Biddison WE, Wiley DC. 1996. Assembly, specific binding, and crystallization of a human TCR-alphabeta with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2. J Immunol 157: 54035410.
  • Gessian A, Yanagihara R, Franchini G, Garruto RM, Jenkins CL, Ajdukiewicz AB, Gallo RC, Gajdusek DC. 1991. Highly divergent molecular variants of human T-lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands. Proc Natl Acad Sci USA 88: 76947698.
  • Giebler HA, Loring JE, van Orden K, Colgin MA, Garrus JE, Escudero KW, Brauweiler A, Nyborg JK. 1997. Anchoring of CREB binding protein to the human T-cell leukemia virus type 1 promoter: A molecular mechanism of Tax transactivation. Mol Cell Biol 17: 51565164.
  • Gitlin SD, Dittmer J, Shin RC, Brady JN. 1993. Transcriptional activation of the human T-lymphotropic virus type I long terminal repeat by functional interaction of Tax1 and Ets1. J Virol 67: 73077316.
  • Gonzalez-Dunia D, Grimber G, Briand P, Brahic M, Ozden S. 1992. Tissue expression pattern directed in transgenic mice by the LTR of an HTLV-I provirus isolated from a case of tropical spastic paraparesis. Virology 187: 705710.
  • Goren I, Tavor E, Honigman A. 1999. Gene regulation mediated by interaction between HTLV-1 promoter elements and transcription factors Tax and CREB. Virology 256: 303312.
  • Grabbe S, Kampgen E, Schuler G. 2000. Dendritic cells: Multi-lineal and multi-functional. Immunol Today 21: 431433.
  • Greten TF, Slansky JE, Kubota R, Soldan SS, Jaffee EM, Leist TP, Pardoll DM, Jacobson S, Schneck JP. 1998. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19-specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc Natl Acad Sci USA 95: 75687573.
  • Hanon E, Asquith RE, Taylor GP, Tanaka Y, Weber JN, Bangham CR. 2000. High frequency of viral protein expression in human T cell lymphotropic virus type 1-infected peripheral blood mononuclear cells. AIDS Res Hum Retroviruses 16: 17111715.
  • Hara H, Morita M, Iwaki T, Hatae T, Itoyama Y, Kitamoto T, Akizuki S, Goto I, Watanabe T. 1994. Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Exp Med 180: 831839.
  • Harhaj EW, Good L, Xiao G, Sun SC. 1999. Gene expression profiles in HTLV-I-immortalized T cells: Deregulated expression of genes involved in apoptosis regulation. Oncogene 18: 13411349.
  • Hickey WF, Hsu BL, Kimura H. 1991. T-lymphocyte entry into the central nervous system. J Neurosci Res 28: 254260.
  • Hirai H, Suzuki T, Fujisawa J, Inoue J, Yoshida M. 1994. Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor kappa B and induces nuclear translocation of transcription factor NF-kappa B proteins for transcriptional activation. Proc Natl Acad Sci USA 91: 35843588.
  • Hoffman PM, Dhib-Jalbut S, Mikovits JA, Robbins DS, Wolf AL, Bergey GK, Lohrey NC, Weislow OS, Ruscetti FW. 1992. Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures. Proc Natl Acad Sci USA 89: 1178411788.
  • Hollsberg P. 1999. Mechanisms of T-cell activation by human T-cell lymphotropic virus type I. Microbiol Mol Biol Rev 63: 308333.
  • Hollsberg P, Hafler DA. 1993. Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N Engl J Med 328: 11731182.
  • Hou X, Foley S, Cueto M, Robinson MA. 2000. The human T-cell leukemia virus type I (HTLV-I) X region encoded protein p13(II) interacts with cellular proteins. Virology 277: 127135.
  • Iwai K, Mori N, Oie M, Yamamoto N, Fujii M. 2001. Human T-cell leukemia virus type 1 tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells. Virology 279: 3846.
  • Jacobson S. 1996. Cellular immune responses to HTLV-I: Immunopathogenic role in HTLV-I- associated neurologic disease. J Acquir Immune Defic Syndr Hum Retrovirol 13: S100S106.
  • Jacobson S, Raine CS, Mingioli ES, McFarlin DE. 1988. Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis. Nature 331: 540543.
  • Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, Bunce M, Ogg GS, Welsh KI, Weber JN, Lloyd AL, Nowak MA, Nagai M, Kodama D, Izumo S, Osame M, Bangham CR. 1999. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci USA 96: 38483853.
  • Jeffery KJ, Siddiqui AA, Bunce M, Lloyd AL, Vine AM, Witkover AD, Izumo S, Usuku K, Welsh KI, Osame M, Bangham CR. 2000. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol 165: 72787284.
  • Johnson JM, Nicot C, Fullen J, Ciminale V, Casareto L, Mulloy JC, Jacobson S, Franchini G. 2001. Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein. J Virol 75: 60866094.
  • Josephs SF, Wong-Staal F, Manzari V, Gallo RC, Sodroski JG, Trus MD, Perkins D, Patarca R, Haseltine WA. 1984. Long terminal repeat structure of an American isolate of type I human T-cell leukemia virus. Virology 139: 340345.
  • Kanamori H, Suzuki N, Siomi H, Nosaka T, Sato A, Sabe H, Hatanaka M, Honjo T. 1990. HTLV-1 p27rex stabilizes human interleukin-2 receptor alpha chain mRNA. EMBO J 9: 41614166.
  • Kasai T, Ikeda H, Tomaru U, Yamashita I, Ohya O, Morita K, Wakisaka A, Matsuoka E, Moritoyo T, Hashimoto K, Higuchi I, Izumo S, Osame M, Yoshiki T. 1999. A rat model of human T lymphocyte virus type I (HTLV-I) infection: In situ detection of HTLV-I provirus DNA in microglia/macrophages in affected spinal cords of rats with HTLV-I-induced chronic progressive myeloneuropathy. Acta Neuropathol (Berl) 97: 107112.
  • Kashanchi F, Duvall JF, Lindholm PF, Radonovich MF, Brady JN. 1993. Sequences downstream of the RNA initiation site regulate human T-cell lymphotropic virus type I basal gene expression. J Virol 67: 28942902.
  • Kashanchi F, Duvall JF, Dittmer J, Mireskandari A, Reid RL, Gitlin SD, Brady JN. 1994. Involvement of transcription factor YB-1 in human T-cell lymphotropic virus type I basal gene expression. J Virol 68: 561565.
  • Kaufmann A, Salentin R, Gemsa D, Sprenger H. 2001. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages. J Leukoc Biol 69: 248252.
  • Kawa K, Nishiuchi R, Okamura T, Igarashi H. 1998. Eradication of human T-lymphotropic virus type 1 by allogeneic bone-marrow transplantation. Lancet 352: 10341035.
  • Kazanji M, Ureta-Vidal A, Ozden S, Tangy F, de Thoisy B, Fiette L, Talarmin A, Gessain A, de The G. 2000. Lymphoid organs as a major reservoir for human T-cell leukemia virus type 1 in experimentally infected squirrel monkeys (Saimiri sciureus): Provirus expression, persistence, and humoral and cellular immune responses. J Virol 74: 48604867.
  • Kimzey AL, Dynan WS. 1998. Specific regions of contact between human T-cell leukemia virus type I Tax protein and DNA identified by photocross-linking. J Biol Chem 273: 1376813775.
  • Kimzey AL, Dynan WS. 1999. Identification of a human T-cell leukemia virus type I tax peptide in contact with DNA. J Biol Chem 274: 3422634232.
  • Kira J, Koyanagi Y, Yamada T, Itoyama Y, Goto I, Yamamoto N, Sasaki H, Sakaki Y. 1991. Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: A quantitative polymerase chain reaction study. Ann Neurol 29: 194201.
  • Kira J, Itoyama Y, Koyanagi Y, Tateishi J, Kishikawa M, Akizuki S, Kobayashi I, Toki N, Sueishi K, Sato H, Sakaki JA, Mora CA, Jacobson S. 1992. Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy. Ann Neurol 31: 3945.
  • Komurian F, Pelloquin F, de The G. 1991. In vivo genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologies. J Virol 65: 37703778.
  • Koralnik IJ, Lemp JF Jr, Gallo RC, Franchini G. 1992. In vitro infection of human macrophages by human T-cell leukemia/lymphotropic virus type I (HTLV-I). AIDS Res Hum Retroviruses 8: 18451849.
  • Koralnik IJ, Fullen J, Franchini G. 1993. The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J Virol 67: 23602366.
  • Koyanagi Y, Itoyama Y, Nakamura N, Takamatsu K, Kira J, Iwamasa T, Goto I, Yamamoto N. 1993. In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology 196: 2533.
  • Kubota R, Umehara F, Izumo S, Ijichi S, Matsumuro K, Yashiki S, Fujiyoshi T, Sonoda S, Osame M. 1994. HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. J Neuroimmunol 53: 2329.
  • Kubota S, Hatanaka M, Pomerantz RJ. 1996. Nucleo-cytoplasmic redistribution of the HTLV-I Rex protein: Alterations by coexpression of the HTLV-I p21x protein. Virology 220: 502507.
  • Kuroda Y, Matsui M. 1993. Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathy. J Neuroimmunol 42: 223226.
  • Kuroda Y, Matsui M, Takashima H, Kurohara K. 1993. Granulocyte-macrophage colony-stimulating factor and interleukin-1 increase in cerebrospinal fluid, but not in serum, of HTLV-I-associated myelopathy. J Neuroimmunol 45: 133136.
  • Kuroda Y, Matsui M, Kikuchi M, Kurohara K, Endo C, Yukitake M, Matsuda Y, Tokunaga O, Komine-Sakaki A, Kawaguchi R. 1994. In situ demonstration of the HTLV-I genome in the spinal cord of a patient with HTLV-I-associated myelopathy. Neurology 44: 22952299.
  • Kwok RP, Laurance ME, Lundblad JR, Goldman PS, Shih H, Connor LM, Marriott SJ, Goodman RH. 1996. Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP. Nature 380: 642646.
  • Lairmore MD, Albrecht B, D'Souza C, Nisbet JW, Ding W, Bartoe JT, Green PL, Zhang W. 2000. In vitro and in vivo functional analysis of human T cell lymphotropic virus type 1 pX open reading frames I and II. AIDS Res Hum Retroviruses 16: 17571764.
  • Leclercq I, Mortreux F, Cavrois M, Leroy A, Gessain A, Wain-Hobson S, Wattel E. 2000a. Host sequences flanking the human T-cell leukemia virus type 1 provirus in vivo. J Virol 74: 23052312.
  • Leclercq I, Mortreux F, Gabet AS, Jonsson CB, Wattel E. 2000b. Basis of HTLV type 1 target site selection. AIDS Res Hum Retroviruses 16: 16531659.
  • Lee J, Mehta K, Blick MB, Gutterman JU, Lopez-Berestein G. 1987. Expression of c-fos, c-myb, and c-myc in human monocytes: Correlation with monocytic differentiation. Blood 69: 15421545.
  • Lehky TJ, Fox CH, Koenig S, Levin MC, Flerlage N, Izumo S, Sato E, Raine CS, Osame M, Jacobson S. 1995. Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol 37: 167175.
  • Lenzmeier BA, Nyborg JK. 1997. In vitro transcription of human T-cell leukemia virus type 1 is RNA polymerase II dependent. J Virol 71: 25772580.
  • Lenzmeier BA, Giebler HA, Nyborg JK. 1998. Human T-cell leukemia virus type 1 Tax requires direct access to DNA for recruitment of CREB binding protein to the viral promoter. Mol Cell Biol 18: 721731.
  • Leung K, Nabel GJ. 1988. HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor. Nature 333: 776778.
  • Levin MC, Lehky TJ, Flerlage AN, Katz D, Kingma DW, Jaffe ES, Heiss JD, Patronas N, McFarland HF, Jacobson S. 1997. Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease. N Engl J Med 336: 839845.
  • Levin MC, Krichavsky M, Fox RJ, Lehky T, Jacobson S, Fox C, Kleghorn F, White J, Young N, Edwards RJ, Jack NE, Bartholomew C. 1997. Extensive latent retroviral infection in bone marrow of patients with HTLV-I-associated neurologic disease. Blood 89: 346348.
  • Levin MC, Krichavsky M, Berk J, Foley S, Rosenfeld M, Dalmau J, Chang G, Posner JB, Jacobson S. 1998. Neuronal molecular mimicry in immune-mediated neurologic disease. Ann Neurol 44: 8798.
  • Li XC, Demirci G, Ferrari-Lacraz S, Groves C, Coyle A, Malek TR, Strom TB. 2001. IL-15 and IL-2: A matter of life and death for T cells in vivo. Nat Med 7: 114118.
  • Lindholm PF, Marriott SJ, Gitlin SD, Bohan CA, Brady JN. 1990. Induction of nuclear NF-kappa B DNA binding activity after exposure of lymphoid cells to soluble tax1 protein. New Biol 2: 10341043.
  • Lindholm PF, Reid RL, Brady JN. 1992. Extracellular Tax1 protein stimulates tumor necrosis factor-beta and immunoglobulin kappa light chain expression in lymphoid cells. J Virol 66: 12941302.
  • Liu YJ, Kanzler H, Soumelis V, Gilliet M. 2001. Dendritic cell lineage, plasticity, and cross-regulation. Nat Immunol 2: 585589.
  • Lunardi-Iskandar Y, Gessain A, Lam VH, Gallo RC. 1993. Abnormal in vitro proliferation and differentiation of T cell colony-forming cells in patients with tropical spastic paraparesis/human T lymphocyte virus type I (HTLV-I)-associated myeloencephalopathy and healthy HTLV-I carriers. J Exp Med 177: 741750.
  • Macatonia SE, Cruickshank JK, Rudge P, Knight SC. 1992. Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. AIDS Res Hum Retroviruses 8: 16991706.
  • Makino M, Shimokubo S, Wakamatsu SI, Izumo S, Baba M. 1999. The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis. J Virol 73: 45754581.
  • Makino M, Wakamatsu S, Shimokubo S, Arima N, Baba M. 2000. Production of functionally deficient dendritic cells from HTLV-I-infected monocytes: Implications for the dendritic cell defect in adult T cell leukemia. Virology 274: 140148.
  • Manns A, Miley WJ, Wilks RJ, Morgan OS, Hanchard B, Wharfe G, Cranston B, Maloney E, Welles SL, Blattner WA, Waters D. 1999. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection. J Infect Dis 180: 14871493.
  • Mansky LM. 2000. In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy. J Virol 74: 95259531.
  • Marriott SJ, Lindholm PF, Brown KM, Gitlin SD, Duvall JF, Radonovich MF, Brady JN. 1990. A 36-kilodalton cellular transcription factor mediates an indirect interaction of human T-cell leukemia/lymphoma virus type I TAX1 with a responsive element in the viral long terminal repeat. Mol Cell Biol 10: 41924201.
  • Marriott SJ, Trinh D, Brady JN. 1992. Activation of interleukin-2 receptor alpha expression by extracellular HTLV-I Tax1 protein: A potential role in HTLV-I pathogenesis. Oncogene 7: 17491755.
  • Masquilier D, Sassone-Corsi P. 1992. Transcriptional cross-talk: Nuclear factors CREM and CREB bind to AP-1 sites and inhibit activation by Jun. J Biol Chem 267: 2246022466.
  • Mendez E, Kawanishi T, Clemens K, Siomi H, Soldan SS, Calabresi P, Brady J, Jacobson S. 1997. Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) Tax: Induction of tumor necrosis factor alpha and susceptibility to lysis by CD8+ HTLV-1-specific cytotoxic T cells. J Virol 71: 91439149.
  • Mick JE, Colgin MA, Brauweiler A, Nyborg JK. 2000. Analysis of CREB mutants in Tax complex formation and trans-activation. AIDS Res Hum Retroviruses 16: 15971601.
  • Migone TS, Lin JX, Cereseto A, Mulloy JC, O'Shea JJ, Franchini G, Leonard WJ. 1995. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 269: 7981.
  • Miwa M, Kushida S, Maeda N, Fang J, Kawamura T, Kameyama T, Uchida K. 1997. Pathogenesis and prevention of HTLV-1-associated diseases. Leukemia 11(Suppl): 6566.
  • Mogensen TH, Paludan SR. 2001. Molecular pathways in virus-induced cytokine production. Microbiol Mol Biol Rev 65: 131150.
  • Mohle R, Bautz F, Rafii S, Moore MA, Brugger W, Kanz L. 1998. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 91: 45234530.
  • Mollinedo F, Gajate C, Tugores A, Flores I, Naranjo JR. 1993. Differences in expression of transcription factor AP-1 in human promyelocytic HL-60 cells during differentiation towards macrophages versus granulocytes. Biochem J 294: 137144.
  • Moritoyo T, Reinhart TA, Moritoyo H, Sato E, Izumo S, Osame M, Haase AT. 1996. Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes. Ann Neurol 40: 8490.
  • Mortreux F, Kazanji M, Gabet AS, de Thoisy B, Wattel E. 2001. Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus). J Virol 75: 10831089.
  • Moser B, Loetscher P. 2001. Lymphocyte traffic control by chemokines. Nat Immunol 2: 123128.
  • Muchardt C, Seeler JS, Nirula A, Gong S, Gaynor R. 1992. Transcription factor AP-2 activates gene expression of HTLV-I. EMBO J 11: 25732581.
  • Mulloy JC, Crownley RW, Fullen J, Leonard WJ, Franchini G. 1996. The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gammac chains and affects their expression on the cell surface. J Virol 70: 35993605.
  • Nagafuji K, Harada M, Teshima T, Eto T, Takamatsu Y, Okamura T, Murakawa M, Akashi K, Niho Y. 1993. Hematopoietic progenitor cells from patients with adult T-cell leukemia–lymphoma are not infected with human T-cell leukemia virus type 1. Blood 82: 28232828.
  • Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S, Osame M. 1998. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: High proviral load strongly predisposes to HAM/TSP. J Neurovirol 4: 586593.
  • Nagai M, Kubota R, Greten TF, Schneck JP, Leist TP, Jacobson S. 2001. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: Correlation with HTLV-I provirus load. J Infect Dis 183: 197205.
  • Nagai M, Brennan MB, Sakai JA, Mora CA, Jacobson S. 2001. CD8+ T cells are an in vivo reservoir for human T-cell lymphotropic virus type I. Blood 98: 18581861.
  • Nakamura S, Nagano I, Yoshioka M, Shimazaki S, Onodera J, Kogure K. 1993. Detection of tumor necrosis factor-alpha-positive cells in cerebrospinal fluid of patients with HTLV-I-associated myelopathy. J Neuroimmunol 42: 127130.
  • Nerurkar VR, Babu PG, Song KJ, Melland RR, Gnanamuthu C, Saraswathi NK, Chandy M, Godec MS, John TJ, Yanagihara R. 1993. Sequence analysis of human T cell lymphotropic virus type I strains from southern India: Gene amplification and direct sequencing from whole blood blotted onto filter paper. J Gen Virol 74: 27992805.
  • Neumann M, Fries H, Scheicher C, Keikavoussi P, Kolb-Maurer A, Brocker E, Serfling E, Kampgen E. 2000. Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells. Blood 95: 277285.
  • Newbound GC, Andrews JM, O'Rourke JP, Brady JN, Lairmore MD. 1996. Human T-cell lymphotropic virus type 1 Tax mediates enhanced transcription in CD4+ T lymphocytes. J Virol 70: 21012106.
  • Nicot C, Mulloy JC, Ferrari MG, Johnson JM, Fu K, Fukumoto R, Trovato R, Fullen J, Leonard WJ, Franchini G. 2001. HTLV-1 p12(I) protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary peripheral blood mononuclear cells. Blood 98: 823829.
  • Nyborg JK, Dynan WS. 1990. Interaction of cellular proteins with the human T-cell leukemia virus type I transcriptional control region. Purification of cellular proteins that bind the 21-base pair repeat elements. J Biol Chem 265: 82308236.
  • Nyborg JK, Dynan WS, Chen IS, Wachsman W. 1988. Binding of host-cell factors to DNA sequences in the long terminal repeat of human T-cell leukemia virus type I: Implications for viral gene expression. Proc Natl Acad Sci USA 85: 14571461.
  • Ohbo K, Sugamura K, Sekizawa T, Kogure K. 1991. Interleukin-6 in cerebrospinal fluid of HTLV-I-associated myelopathy. Neurology 41: 594595.
  • Osame M, Janssen R, Kubota H, Nishitani H, Igata A, Nagataki S, Mori M, Goto I, Shimabukuro H, Khabbaz R, Kaplan J. 1990. Nationwide survey of HTLV-I-associated myelopathy in Japan: Association with blood transfusion. Ann Neurol 28: 5056.
  • Paine E, Garcia J, Philpott TC, Shaw G, Ratner L. 1991. Limited sequence variation in human T-lymphotropic virus type 1 isolates from North American and African patients. Virology 182: 111123.
  • Perini G, Wagner S, Green MR. 1995. Recognition of bZIP proteins by the human T-cell leukaemia virus transactivator Tax. Nature 376: 602605.
  • Popovic M, Lange-Wantzin G, Sarin PS, Mann D, Gallo RC. 1983. Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma virus. Proc Natl Acad Sci USA 80: 54025406.
  • Pulendran B, Banchereau J, Maraskovsky E, Maliszewski C. 2001. Modulating the immune response with dendritic cells and their growth factors. Trends Immunol 22: 4147.
  • Pulendran B, Palucka K, Banchereau J. 2001. Sensing pathogens and tuning immune responses. Science 293: 253256.
  • Randolph GJ, Beaulieu S, Lebecque S, Steinman RM, Muller WA. 1998. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282: 480483.
  • Ratner L, Philpott T, Trowbridge DB. 1991. Nucleotide sequence analysis of isolates of human T-lymphotropic virus type 1 of diverse geographical origins. AIDS Res Hum Retroviruses 7: 923941.
  • Ratner L, Portis T, Robek M, Harding J, Grossman W. 2000. Studies of the immortalizing activity of HTLV type 1 Tax, using an infectious molecular clone and transgenic mice. AIDS Res Hum Retroviruses 16: 16471651.
  • Reddy TR, Tang H, Li X, Wong-Staal F. 1997. Functional interaction of the HTLV-1 transactivator Tax with activating transcription factor-4 (ATF4). Oncogene 14: 27852792.
  • Renjifo B, Chou K, Soto Ramirez L, Garcia Vallejo F, Essex M. 1996. Human T cell leukemia virus type I (HTLV-I) molecular genotypes and disease outcome. J Acquir Immune Defic Syndr Hum Retrovirol 13: S146153.
  • Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG. 1990. In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol 64: 56825687.
  • Robek MD, Ratner L. 1999. Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J Virol 73: 48564865.
  • Romero IA, Prevost MC, Perret E, Adamson P, Greenwood J, Couraud PO, Ozden S. 2000. Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: Mechanisms of viral entry into the central nervous system. J Virol 74: 60216030.
  • Rosenzweig M, Connole M, Glickman R, Yue SP, Noren B, DeMaria M, Johnson RP. 2001. Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34(+) hematopoietic cells. Blood 97: 19511959.
  • Ross HL, Gartner S, McArthur JC, Corboy JR, McAllister JJ, Millhouse S, Wigdahl B. 2001. HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity. J Neurovirol 7: 235249.
  • Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW. 1993. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci USA 90: 65916595.
  • Saggioro D, Forino M, Penzo A, Pesce M, Oliviero S, Chieco-Bianchi L. 1994. Tax-induced HTLV-I LTR transcriptional activation is modulated by phosphorylation. Biochem Biophys Res Commun 205: 666673.
  • Sakai JA, Nagai M, Brennan MB, Mora CA, Jacobson S. 2001. In vitro spontaneous lymphoproliferation in patients with human T-cell lymphotropic virus type I-associated neurologic disease: Predominant expansion of CD8+ T cells. Blood 98: 15061511.
  • Santambrogio L, Belyanskaya SL, Fischer FR, Cipriani B, Brosnan CF, Ricciardi-Castagnoli P, Stern LJ, Strominger JL, Riese R. 2001. Developmental plasticity of CNS microglia. Proc Natl Acad Sci USA 98: 62956300.
  • Sassone-Corsi P, Ransone LJ, Verma IM. 1990. Cross-talk in signal transduction: TPA-inducible factor jun/AP-1 activates cAMP-responsive enhancer elements. Oncogene 5: 427431.
  • Scoggin KE, Ulloa A, Nyborg JK. 2001. The oncoprotein tax binds the src-1-interacting domain of cbp/p300 to mediate transcriptional activation. Mol Cell Biol 21: 55205530.
  • Seeler JS, Muchardt C, Podar M, Gaynor RB. 1993. Regulatory elements involved in tax-mediated transactivation of the HTLV-I LTR. Virology 196: 442450.
  • Selmaj KW, Raine CS. 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23: 339346.
  • Szymocha R, Akaoka H, Dutuit M, Malcus C, Didier-Bazes M, Belin MF, Giraudon P. 2000. Human T-cell lymphotropic virus type 1-infected T lymphocytes impair catabolism and uptake of glutamate by astrocytes via Tax-1 and tumor necrosis factor alpha. J Virol 74: 64336441.
  • Szymocha R, Brisson C, Bernard A, Akaoka H, Belin MF, Giraudon P. 2000. Long-term effects of HTLV-1 on brain astrocytes: Sustained expression of Tax-1 associated with synthesis of inflammatory mediators. J Neurovirol 6: 350357.
  • Tanimura A, Teshima H, Fujisawa J, Yoshida M. 1993. A new regulatory element that augments the Tax-dependent enhancer of human T-cell leukemia virus type 1 and cloning of cDNAs encoding its binding proteins. J Virol 67: 53755382.
  • Tendler CL, Greenberg SJ, Burton JD, Danielpour D, Kim SJ, Blattner WA, Manns A, Waldmann TA. 1991. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: Alternate molecular mechanisms underlying retroviral pathogenesis. J Cell Biochem 46: 302311.
  • Tillmann M, Wessner R, Wigdahl B. 1994. Identification of human T-cell lymphotropic virus type I 21-base pair repeat-specific and glial cell-specific DNA-protein complexes. J Virol 68: 45974608.
  • Torgeman A, Mor-Vaknin N, Aboud M. 1999. Spl is involved in a protein kinase C-independent activation of human T cell leukemia virus type I long terminal repeat by 12-O-tetradecanoyl phorbol-13-acctate.
  • Trejo SR, Fahl WE, Ratner L. 1997. The tax protein of human T-cell leukemia virus type 1 mediates the transactivation of the c-sis/platelet-derived growth factor-B promoter through interactions with the zinc finger transcription factors Sp1 and NGFI-A/Egr-1. J Biol Chem 272: 2741127421.
  • Uchiyama T. 1997. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol 15: 1537.
  • Umehara F, Izumo S, Nakagawa M, Ronquillo AT, Takahashi K, Matsumuro K, Sato E, Osame M. 1993. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 52: 424430.
  • Umehara F, Nakamura A, Izumo S, Kubota R, Ijichi S, Kashio N, Hashimoto K, Usuku K, Sato E, Osame M. 1994. Apoptosis of T lymphocytes in the spinal cord lesions in HTLV-I-associated myelopathy: A possible mechanism to control viral infection in the central nervous system. J Neuropathol Exp Neurol 53: 617624.
  • Umehara F, Izumo S, Ronquillo AT, Matsumuro K, Sato E, Osame M. 1994. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 53: 7277.
  • Umehara F, Izumo S, Takeya M, Takahashi K, Sato E, Osame M. 1996. Expression of adhesion molecules and monocyte chemoattractant protein-1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy. Acta Neuropathol 91: 343350.
  • Umehara F, Okada Y, Fujimoto N, Abe M, Izumo S, Osame M. 1998. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 57: 839849.
  • Valledor AF, Borras FE, Cullell-Young M, Celada A. 1998. Transcription factors that regulate monocyte/macrophage differentiation. J Leukoc Biol 63: 405417.
  • Van Orden K, Yan JP, Ulloa A, Nyborg JK. 1999. Binding of the human T-cell leukemia virus Tax protein to the coactivator CBP interferes with CBP-mediated transcriptional control. Oncogene 18: 37663772.
  • Viney JL, Mowat AM, O'Malley JM, Williamson E, Fanger NA. 1998. Expanding dendritic cells in vivo enhances the induction of oral tolerance. J Immunol 160: 58155825.
  • Wagner S, Green MR. 1993. HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science 262: 395399.
  • Wakamatsu S, Makino M, Tei C, Baba M. 1999. Monocyte-driven activation-induced apoptotic cell death of human T-lymphotropic virus type I-infected T cells. J Immunol 163: 39143919.
  • Waldmann TA, Dubois S, Tagaya Y. 2001. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: Implications for immunotherapy. Immunity 14: 105110.
  • Weber C, Weber KS, Klier C, Gu S, Wank R, Horuk R, Nelson PJ. 2001. Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H)1-like/CD45RO(+) T cells. Blood 97: 11441146.
  • Wekerle H, Sun D, Oropeza-Wekerle RL, Meyermann R. 1987. Immune reactivity in the nervous system: Modulation of T-lymphocyte activation by glial cells. J Exp Biol 132: 4357.
  • Wessner R, Wigdahl B. 1997. AP-1 derived from mature monocytes and astrocytes preferentially interacts with the HTLV-I promoter central 21 bp repeat. Leukemia 11(Suppl 3): 2124.
  • Wessner R, Tillmann-Bogush M, Wigdahl B. 1995. Characterization of a glial cell-specific DNA-protein complex formed with the human T cell lymphotropic virus type I (HTLV-I) enhancer. J Neurovirol 1: 6277.
  • Wessner R, Yao J, Wigdahl B. 1997. Sp family members preferentially interact with the promoter proximal repeat within the HTLV-I enhancer. Leukemia 11(Suppl 3): 1013.
  • Wodarz D, Nowak MA, Bangham CR. 1999. The dynamics of HTLV-I and the CTL response. Immunol Today 20: 220227.
  • Xiao BG, Link H. 1999. Is there a balance between microglia and astrocytes in regulating Th1/Th2-cell responses and neuropathologies? Immunol Today 20: 477479.
  • Xu X, Brown DA, Kitajima I, Bilakovics J, Fey LW, Nerenberg MI. 1994. Transcriptional suppression of the human T-cell leukemia virus type I long terminal repeat occurs by an unconventional interaction of a CREB factor with the R region. Mol Cell Biol 14: 53715383.
  • Yan JP, Garrus JE, Giebler HA, Stargell LA, Nyborg JK. 1998. Molecular interactions between the coactivator CBP and the human T-cell leukemia virus Tax protein. J Mol Biol 281: 395400.
  • Yao J, Wigdahl B. 2000. Human T cell lymphotropic virus type I genomic expression and impact on intracellular signaling pathways during neurodegenerative disease and leukemia. Front Biosci 5: D138D168.
  • Yashiki S, Fujiyoshi T, Arima N, Osame M, Yoshinaga M, Nagata Y, Tara M, Nomura K, Utsunomiya A, Hanada S, Tajima K, Sonoda S. 2001. HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: The limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8+ cytotoxic T lymphocytes. AIDS Res Hum Retroviruses 17: 10471061.
  • Yin MJ, Paulssen EJ, Seeler JS, Gaynor RB. 1995. Protein domains involved in both in vivo and in vitro interactions between human T-cell leukemia virus type I tax and CREB. J Virol 69: 34203432.
  • Yoshida M. 1994. Mechanism of transcriptional activation of viral and cellular genes by oncogenic protein of HTLV-1. Leukemia 8(Suppl 1): S51S53.
  • Yoshida M, Miyoshi I, Hinuma Y. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79: 20312035.
  • Zhang W, Nisbet JW, Bartoe JT, Ding W, Lairmore MD. 2000. Human T-lymphotropic virus type 1 p30(II) functions as a transcription factor and differentially modulates CREB-responsive promoters. J Virol 74: 1127011277.
  • Zhao LJ, Giam CZ. 1992. Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction. Proc Natl Acad Sci USA 89: 70707074.